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           Chromosome translocations are products of 
unresolved double-strand DNA breaks (  1  –  4  ) 
and therefore occur frequently at Ig genes be-
cause these loci undergo programmed DNA 
damage during antigen receptor gene diversifi  -
cation. In developing T and B cells, RAG1 and 
RAG2 proteins produce double-strand breaks 
at recombination signal sequences (RSS) found 
adjacent to variable, diversity, and joining (V(D)J) 
gene segments (  5, 6  ). These RSS are found in 
close proximity or within translocation break-
points in numerous B cell lymphomas (for re-
view see references   7   and   8  ). 
  In mature B cells, expression of activation-
induced cytidine deaminase (AID) (  9  –  11  ) leads 
to deamination of cytidine residues in Ig V-J  H   
and Ig switch regions resulting in U:G mis-
matches that are processed to produce somatic 
hypermutations (SHMs) and initiate class switch 
recombination (for review see references   12  –  14  ). 
Double-strand breaks are obligate intermedi-
ates in the class switch reaction, and translo-
cations involving switch regions are frequently 
found in sporadic Burkitt  ’  s lymphoma, diff  use 
large B cell lymphoma, and multiple myeloma, 
suggesting that AID is responsible for the le-
sions that lead to such translocations (  15  –  22  ). 
Consistent with this idea, AID-induced breaks 
in the switch region activate the cellular DNA 
damage response machinery (  23  ), and AID is 
essential for   c-myc   translocations to the Ig switch 
region in   IL-6   transgenic (tg) (  24, 25  ). In addi-
tion, AID appears to target several oncogenes 
that are frequently mutated and often trans-
located to antibody genes in mature B cell 
malignancies (26–30). In agreement with these 
observations, deregulated expression of AID is 
associated with malignancy (  31  –  34  ). 
  Double-strand breaks are not obligate in-
termediates in SHM of the Ig V-J  H   (  35  ). Nev-
ertheless, duplications or deletions that would 
necessitate a double-strand break make up 6% 
of all the Ig V-J  H   region  –  associated somatic 
mutations, and DNA breaks can be detected 
in this region in B cells undergoing mutation 
(  36  –  42  ). In addition, endemic Burkitt  ’  s lym-
phoma, multiple myeloma, follicular lymphoma, 
and diff  use large B cell lymphoma contain mu-
tated V genes as well as translocations to the Ig 
V-J  H   or Ig V-J  L   regions (for review see references 
  7  ,   8  , and   43  ). This suggests that translocations in 
these malignancies may have occurred in ma-
ture B cells that express AID but not RAG1/2 
(44    ), and that some Ig V-J  H   region  –  associated 
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  Chromosome translocations between oncogenes and the region spanning the immuno-
globulin (Ig) heavy chain (  IgH  ) variable (V), diversity (D), and joining (J) gene segments 
(Ig V-J  H   region) are found in several mature B cell lymphomas in humans and mice. The 
breakpoints are frequently adjacent to the recombination signal sequences targeted by 
recombination activating genes 1 and 2 during antigen receptor assembly in pre  –  B cells, 
suggesting that these translocations might be the result of aberrant V(D)J recombination. 
However, in mature B cells undergoing activation-induced cytidine deaminase (AID)-dependent 
somatic hypermutation (SHM), duplications or deletions that would necessitate a double-
strand break make up 6% of all the Ig V-J  H   region  –  associated somatic mutations. Further-
more, DNA breaks can be detected at this locus in B cells undergoing SHM. To determine 
whether SHM might induce   c-myc   to Ig V-J  H   translocations, we searched for such events in 
both interleukin (IL) 6 transgenic (  IL-6   tg) and   AID      /      IL-6   tg mice. Here, we report that 
  AID   is required for   c-myc   to Ig V-J  H   translocations induced by IL-6. 2226 AID MEDIATES V REGION TRANSLOCATIONS | Dorsett et al.
whether AID is required for translocations between the Ig 
V-J  H   region and   c-myc  , we generated   AID  -defi  cient   IL-6   tg 
mice (  AID       /      IL-6   tg) by breeding (  24  ).   AID       /      IL-6   tg mice 
developed lymph node hyperplasia and plasmacytosis with a 
slightly delayed onset compared with   IL-6   tg mice, and there 
was no detectable class switching in the   AID       /      IL-6   tg mice 
(  Fig. 1, A and B  ) (  24  ).   
  To document translocations between the Ig V-J  H   region 
and   c-myc  , we developed PCR assays for these events and ex-
amined cells from hyperplastic lymph nodes from   IL-6   tg and 
  AID       /       IL-6   tg mice (  Fig. 2 A  ).   Southern blotting and DNA 
sequencing were used to verify candidate translocations (  Figs. 
2 and 3  ). Assaying four diff  erent lymph node pools per mouse 
for derivative 12 and derivative 15 translocations (  Fig. 2 A  ), 
we identifi  ed 37 unique translocations in 14   IL-6   tg mice, but 
none in 12   AID       /      IL-6   tg mice (P   0.0025) (  Fig. 2 C  ). 
Derivative 12 and 15 translocations were similar in both the 
number of translocations identifi  ed (21 and 16, respectively) 
translocations are byproducts of lesions induced by AID dur-
ing hypermutation. To ascertain the extent to which AID 
contributes to genomic instability at the   IgH   locus, we tested 
if AID is required for translocations between   c-myc   and the Ig 
V-J  H   region in   IL-6   tg mice. 
    RESULTS   
    IL-6   tg mice develop hyperplastic lymph nodes that contain 
large numbers of class-switched plasmacytes, a portion of 
which express GL7 and CD138 (  24, 45, 46  ). Plasmacytosis is 
believed to develop in these mice because IL-6 attenuates 
apoptosis and promotes proliferation and diff  erentiation of 
late-stage B cells, allowing for the accumulation of transloca-
tions between   IgH   and   c-myc   (  45  ). Although a majority of the 
  c-myc   translocation breakpoints are at the Ig switch region, 
a small fraction occur at the V-J  H   region (  46  ) and therefore 
resemble the translocations found in endemic Burkitt  ’  s lym-
phoma (for review see references   7   and   8  ). To determine 
  Figure 1.     Characterization of IL-6 tg and AID      /      IL-6 tg mice. (A) Flow cytometry analysis of cells from hyperplastic lymph nodes from IL-6 tg and 
AID      /     IL-6 tg mice. Numbers indicate percentages of cells in a given quadrant. (B) AID accelerates the development of disease in IL-6 tg mice. IL-6 tg 
mice and AID      /     IL-6 tg mice were killed when they developed enlarged lymph nodes. The average time of death for IL-6 tg was 5.5 mo (  n     8) and 9.2 mo 
for AID      /     IL-6 tg mice (  n     8; P   0.0001476 using a two-tailed Student  ’  s   t   test assuming unequal variance). Each point represents one mouse, and the 
black bars indicate the average time of death.     JEM VOL. 204, September 3, 2007 
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in   IL-6   tg mice, where a majority of the breakpoints are in 
the fi  rst exon of   c-myc   (  Fig. 3  ) (  24  ). 
  Although there was no correlation between the position 
of the breakpoints and the RGYW motifs, which are the 
preferred targets of AID, the translocated Ig V-J  H   region was 
somatically mutated at a frequency of     0.6       10       3   muta-
tions per basepair (  Fig. 4  ).   This rate of mutation is similar to 
that reported for the Ig V-J  H   region in B cells undergoing 
hypermutation (  47  ). Derivative 12 and 15   IgH   sequences had 
a similar frequency of hypermutation, suggesting that SHM 
must have occurred before or during translocation. Interest-
ingly, the overall position of the mutations mirrored the posi-
tions of the translocation breakpoints (compare   Figs. 3 and 4  ), 
supporting the idea that regions prone to SHM are suscep-
tible to translocations. Excluding nucleotide insertions at 
the breakpoint, the rate of mutation within 20 bp of either 
side of the translocation breakpoints was almost 10-fold 
higher (5.4       10       3  ) than that seen overall for   IgH   in our 
translocations. This implies that   c-myc/IgH   translocations are 
as well as in their breakpoint distribution along the chromo-
some (  Fig. 3  ), providing strong evidence that variable region 
translocations are reciprocal. As expected,   c-myc   to Ig switch 
region translocations were far more frequent (  Fig. 2 B  ) (  24, 46  ). 
We conclude that translocations between   c-myc   and the Ig 
V-J  H   region are AID dependent in   IL-6   tg mice. 
  To gain further insight into the etiology of the identifi  ed 
translocations, we analyzed and mapped the breakpoints. Se-
quence analysis revealed that the majority of the breakpoints 
were in or around J  H   segments, as commonly seen for onco-
genic translocations in B cell non-Hodgkin  ’  s (  Fig. 3  ) (for re-
view see references   7   and   8  ).    Junction sequences resembled 
those previously characterized for   c-myc   to Ig switch region 
translocations from   IL-6   tg mice (  24  ) in that they involved 
either blunt ends or 1  –  3 nucleotide stretches of micro-
  homology or nucleotide insertions (  Tables I and II  ), implying 
that nonhomologous end joining resolves these breaks.   Fi-
nally, the translocation breakpoints in   c-myc   were all in the 
fi  rst intron, which diff  ers from those to the Ig switch region 
  Figure 2.     C-myc to Ig V-J  H   region. (A) Diagram of translocation assay for detecting derivative 12 and 15 chromosomal translocations from c-myc to 
the Ig V-J  H   region. Primer set 1 is indicated in the diagram for derivative 12 (see Materials and methods). The circles at the end of each chromosome rep-
resent the centromere. (B) Comparison of c-myc translocations to the IgH V-J  H   versus switch region. Representative PCRs from three IL-6 tg and one 
AID      /     IL-6 tg mouse. Primer set 1 was used to detect translocations to the variable region. Each lane represents amplifi  cation products from 10  5   cells.  The 
ethidium bromide–stained gels at the top were probed for c-myc, stripped, and then probed for IgH to verify translocations. (C) Graph shows the number 
of unique c-myc to Ig V-J  H   region translocations identifi  ed in 14 IL-6 tg mice. No translocations were identifi  ed in the same analysis of 12 AID      /    IL-6  tg 
mice (P   0.00284 using a two-tailed Student  ’  s   t   test assuming unequal variance.).     2228 AID MEDIATES V REGION TRANSLOCATIONS | Dorsett et al.
the Ig V-J  H   region in   IL-6   tg mice occur during or after Ig 
V-J  H   region SHM (  28, 47, 48  ). 
    DISCUSSION   
  Molecular characterization of translocations found in lym-
phomas showed that in addition to Ig switch regions, many 
breakpoints are near RSS, suggesting a role for aberrant V(D)J 
resolved through error-prone repair, or that translocation 
breakpoints occur at or immediately adjacent to hypermu-
tated sequences. Discounting mutations within 20 bp of the 
breakpoint, we identifi  ed three mutations in   c-myc  , resulting 
in a mutation rate that is above background (    0.2       10       3  ) 
but approximately threefold lower than the rate observed for 
  IgH   (  Fig. 4  ). These results suggest that   c-myc   translocations to 
  Figure 3.     Translocation breakpoints. Diagram of translocation breakpoints from c-myc to the Ig V-J  H   region. Only primer set 1 is indicated for deriva-
tive 12 (see Materials and methods). The translocations are annotated as the mouse number followed by the translocation number for that mouse. For 
example,   “  2 #2  ”   is mouse 2 translocation number two amplifi  ed from that mouse.     
  Table I.     Derivative  12 
Translocation IgH Jnc c-myc
4 #2 GAGTGTCCTCTCAACCACCA A GATCTGGTGGTCTTTCCCTG
2 #3 GAATACTCAGAAAGTGGTCT CTTTTGCGTTTGGGAGCGAG
3 #3   TTAAACTTTAAGTAAT  G  TCA   t TTAGGACAGTCTTTCTTCCA
2 #4 CTTTTATTCTAAAAACTGAA CGGCCGGTTGGACATTATTG
1 #2 TTAAAAGTCAGTTCTGAATA G ATTACCTTTTGCGTTTGGGA
1 #3 CCCCTGGACCCCTCTTTAGT AGGGAAGACGCCCTGCACCC
3 #1 CCTGGACCCCTCTTTAGT AGGGAAGACGCCCTGCAC
1 #5 GACAGTTTATTTCCCAATTT CT TTGAGGGGCAAACCGGGAG
4 #1 GTTGTAAGGACTCACCTGAG G CATTTCTGACAGCCTGGG
3 #2 CAGCCGGTTCCCTCAGGGAC   TTGGACATTCTTGCTTTGCTA  t
1 #1 CCCCTGGACCCCTCTTAAGT AGGGAAGACGCCCTGCAC
1 #6 GGAGACGGTGACTGAGGTT TCCCGAGGTTACTATGGGC
5 #1 GTCTGCAATGTTCAGAAAAC T AAATTTCAGCTTGGTGCATT
1 #4 CCCTAATTCTCACAAGAGTC TTTTGGCTTTAAAAATAGTG
2 #2   GTTCCTTGACCCCAG  A  AGTC AAGAAGTTGCTATTTTGGCT
6 #1 CACAGAGCATGTGGACTGGC TT AATTGATATGTGTCCTTTG
7 #1 CCAAATAGCCTTGCCACATG GGGCATTTAAATTTCAGCTT
8 #1 ATACCCGACAAAAACCCCAG   t CTTTCTCCTTCAGGTGGCGC
2 #1 GCCTTGCAGGACAGCTTCAC ATGACAGAGGAAAGGGGAAG
3 #4   CTTGACCCCAGTA  t  TCCATAG GAAGACTGCGGTGAGTCGTGA
11 #1   CCTTC  t  TCATACTTCAG  g  TCT CCTGAAAAGAGCTCCTCGAGC
Junction sequences are those that cannot be defi  nitively assigned to c-myc or IgH. Lower case letters indicate mutations, and insertions are in italics. The translocations are 
annotated as the mouse number followed by the translocation number for that mouse. For example   “  2 #2  ”   is mouse 2 translocation number two amplifi  ed from that mouse. 
Jnc., junction.JEM VOL. 204, September 3, 2007 
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of B cells in the germinal center and their rapid rates of divi-
sion, AID-induced double-strand breaks in the Ig V-J  H   re-
gion are not infrequent events (  36  –  39  ). However, to date 
recombination in their etiology. This idea is supported by 
experiments in mice defi   cient in DNA damage response 
and apoptosis pathways that develop spontaneous lympho-
mas harboring oncogenic translocations involving the   TCR   
or   IgH   locus (  1, 2, 49  –  53  ). For example, ataxia telangec-
tasia mutated mice (  ATM       /        ) develop thymic lymphomas 
with   TCR   gene translocations (  54  –  58  ). These translocations 
can be ascribed to V(D)J recombination because they fail to 
occur in the absence of RAG expression (  51, 53  ). Simi-
larly, mice defi  cient in p53 and nonhomologous end joining 
factors or histone H2AX develop RAG-dependent trans-
locations that lead to pro  –  B cell lymphomas (  1, 2, 49, 50, 
52, 59  –  63  ). 
  However, some translocation breakpoints in proximity of 
RSS are found in mature B cell tumors, such as endemic 
  Burkitt  ’  s lymphoma, diff  use large B cell lymphoma, and mul-
tiple myeloma (for review see references   7  ,   8  , and   43  ). These 
trans  locations are believed to arise during or after the germi-
nal center reaction because the Ig genes involved in the trans-
locations are usually somatically mutated (  7  ). Nevertheless, 
they could be   mediated by V(D)J recombination if RAG1/2 
were reexpressed in the germinal center. An alternative pos-
sibility is that the translocations to the Ig V-J  H   region in ma-
ture B cells are byproducts of double-strand DNA breaks 
created by AID during SHM. 
  Although double-strand breaks are not obligate interme-
diates in SHM, a measurable fraction of all Ig hypermutations 
involve deletions or insertions that require repair of double-
strand breaks (  36, 37  ). A region spanning 1  –  2 kbp down-
stream of Ig V  H   genes undergoes somatic mutation at a rate 
of 10    −  3   per basepair per generation in germinal center B cells 
(for review see reference   12  ) (  47  ). Given the large numbers 
  Table II.     Derivative  15 
  Translocation   IgH   Jnc   c-myc 
2 #1 AGGCTCATTTGAGGGAcATG GTTTCCAACGCCCAAAGAA
2 #3  AGTTGGAGATTTTCAGTTTT-AG TCCAACCGGCCGGGTCAG
9 #1 GAGAGCTGTCTTAGTGATTG   t AAGAATGTCCAACCGGCCG
14 #2  AGGTCTGAGACCAGGCTGCT   aaaaat CGGCCGCTACATTCAAGACG
12 #2 ATGTCTGAGTTGCCCAGGGGT G GCGCCGCGTCGCTCGGCCCC
5 #1 TAAAACTTCATTTGTTGGAAG ATCCCTTCTCCAAAGACCTCA
3 #2  AATTATTTCAtTTAAGTGTAT CTTCTCGCTCCCAAACGCAAA
2 #2 TCCGAAACCAGGCACCGC AAA AGGTAATCCCTTCTCCAA
12 #1 GAAGTTGGGAAATAAACTGTC GAtGAAAGACTGTCCTAACCG
13 #1 GTCCAAAATTTTTGTCAATC A AtACAGGGAAAGACCACCAG
10 #1  TTGCTGTCTAGAGAGGTCTG G CTTACCGGGGTTTCCAACGC
1 #1 GAACAATTCCACACAAAGACT C TTAAATTTTACTACGATCAC
1 #2 GAAGGAATTTAAATTGGAAG C CATAGTAACCTCGGGAACCC
1 #3 ACTTTAAAATGTGAGAGGG TT AAAAGGCTCAGGGACGGGT
3 #1  GCCACAGCTGTGGCTGCTGCT GCTGAAATTTAAATGCCCTCT
14 #1  TCAATTTGAGGTCTTGTTTGT AtAGCTCAGTCTCCGGCTATC
Junction sequences are those that cannot be defi  nitively assigned to c-myc or IgH. Lower case letters indicate mutations, and insertions are in italics. The translocations are 
annotated as the mouse number followed by the translocation number for that mouse. For example   “  2 #2  ”   is mouse 2 translocation number two amplifi  ed from that mouse. 
Jnc., junction.
  Figure 4.     Somatic mutations in translocated IgH. Analysis of 32,654 bp 
of IgH sequence from c-myc/IgH translocations identifi  ed 20 different muta-
tions (mutation frequency   0.61       10     3  ), excluding the two mutations 
found within 4 nts of breakpoints. Excluding the three mutations within 
3 nts of the breakpoint, analysis of 16,960 bp of c-myc identifi  ed three differ-
ent mutations (mutation frequency   0.18       10     3  ). The overall mutation 
rate within 20 nts of a breakpoint on either side of the translocation was 
5.4       10     3  . Asterisks indicate mutations within 20 nts of a breakpoint.    2230 AID MEDIATES V REGION TRANSLOCATIONS | Dorsett et al.
  TACCATTTGCGGTGCCTGGTTTCGGAGAGG   (  IgH  ) and   TTGGCT-
TCAGAGGCTGAGGGAGGCGACTG   (  c-myc  ); primer set 2: fi  rst round 
with   GTGCCCCACTCCACTCTTTGTCCCTATGC   (  IgH  ) and   GAAA-
TAAAAGGGGAGGGGGTGTCAAATAATAAGAG   (  c-myc  ), followed 
by nested PCR with   ATCATCCAGGGACTCCACCAACACCATCAC   
(  IgH  ) and   CCTCCCTTCTACACTCTAAACCGCGACGCCAC   (  c-myc  ). 
500 ng DNA (10  5   cells) was amplifi  ed in each 20      l fi  rst-round PCR reac-
tion; 1      l of the fi  rst reaction was template for the nested PCR reaction. 
PCR conditions for the fi  rst round were 94  °  C for the fi  rst 2 min, followed 
by 10 cycles of 94  °  C for 30 s, 61  °  C for 30 s, and 68  °  C for 7 min, followed 
by 19 cycles of 94  °  C for 30 s, 61  °  C for 30 s, 68  °  C for 7min plus 20 s/cycle. 
The conditions for the nested PCR were as follows: 94  °  C for 15 s, 61  °  C 
for 30 s, 68  °  C for 4 min, followed by 15 cycles of 94  °  C for 30 s, 61  °  C for 
30 s, 68  °  C for 4 min plus 20 s/cycle. The combined total number of cycles 
of amplifi  cation was 45. 
  Conditions for amplifi  cation of derivative 15 translocations from c-myc 
to the   IgH   variable region were the same as those for derivative 12, with 
the exception of a 2-min extension time in the fi  rst-round PCR and a 
1-min extension time in the nested PCR. Amplifi  cation of derivative 
15 translocations was performed using the following primers: primer set 3: 
GTTGAGACATGGGTCTGGGTCAGGGAC (  IgH  ) and ATCAGCGGCC-
GCAACCCTCGCCGCCGC (  c-myc  ), followed by a nested PCR reaction 
with CTCTGCCTGCTGGTCTGTGGTGACATTAG (  IgH  ) and GAAGG-
CTGGATTTCCTTTGGGCGTTGG (cmyc). 
  For amplifi  cation of derivative 12   c-myc   to switch region translocations, 
primers described previously (  24  ) were used following the PCR conditions 
described above for primer set 1. 
  All animal experiments were performed in accordance with the rules 
and regulations of The Rockefeller University Institutional Laboratory of 
Animal Care and Use committee. 
  Southern blot analysis.     PCR products from primer set 1 were separated 
on 0.8% agarose gels and denatured for 15 min in 0.4 M NaOH before trans-
fer to nylon membranes and probing with P32 radiolabeled primers. The   IgH   
probe sequence is GGTGGCAGAAGCCACAACCATACATTCCCA, and 
the   c-myc   probe sequence is   GCGCCTCGGCTCTTAGCAGACTGTAT  . 
  Sequencing.     The PCR reactions were separated on 0.8% agarose gels, and 
the bands were gel extracted using the QIAGEN gel extraction kit according 
to the manufacturer  ’  s instructions and sent for direct sequencing. Transloca-
tions were sequenced with the nested PCR primers. If the translocation 
breakpoint was not identifi  ed with the fi  rst round of sequencing, we de-
signed new primers for sequencing to walk along the translocation until we 
reached the breakpoint. 
  Sequence analysis.     PCR products were sent directly for sequencing with-
out cloning so that we could discount the error rate of the polymerase in our 
analysis. Mutations that arose during early PCR cycles could be identifi  ed by 
chromatogram analysis by the presence of more than one base signal for the 
same nucleotide. Such nucleotides were discounted from our analysis. All 
sequenced translocations were aligned using both SeqMan from DNA Star 
and the Codon Code Aligner software. Overlapping traces from all the 
translocation sequences allowed for distinction between real mutations and 
single nucleotide polymorphisms. In the case of   c-myc  , we also amplifi  ed and 
sequenced the fi  rst intron from the   IL-6   tg mouse to verify that the   c-myc   
mutations identifi  ed were not single nucleotide polymorphisms. 
  FACS analysis.     FACS analysis was conducted as described previously (  24  ). 
All antibodies were from BD Biosciences. 
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there has been no direct evidence for the role of AID-depen-
dent Ig V-J  H   region breaks in chromosome rearrangement. 
  AID induces   c-myc   translocations to the Ig switch region 
by a mechanism that resembles class switching in that forma-
tion of the initial lesion requires cytidine deamination and 
uracil removal from DNA (  25  ). However, resolution of the 
lesion proceeds by distinct pathways for switching and trans-
location (  25  ). Factors that act in cis to promote switch region 
synapsis, such as 53BP1 and H2AX, have no impact on   c-myc   
to Ig switch translocations despite their eff  ects on genomic 
stability (  25, 64  ). In contrast, factors that transmit damage 
  signals to the nucleus, such as p53, do not appear to aff  ect 
switching but are essential in suppressing Ig switch transloca-
tions, possibly by promoting the death of cells that overex-
press   c-myc   (  65, 66  ). 
  We have shown that mature B cells in   IL-6   tg mice de-
velop translocations involving   c-myc   and the Ig V-J  H   region 
and that they are AID dependent. These rearrangements 
closely resemble those found in endemic Burkitt  ’  s lymphoma, 
multiple myeloma, and diff  use large B cell lymphoma in that 
both of the translocated genes are hypermutated (for review 
see references   7   and   8  ). Ig V-J  H   regions are direct targets of 
AID, which is likely to produce the DNA double-strand 
break intermediates in the translocation reaction. Although 
translocated   c-myc   was also mutated, germline   c-myc   is not 
thought to be a target for AID (  28  ), and   c-myc   mutation 
was substantially lower than the Ig partner. We speculate that 
  c-myc   mutation may have occurred after the translocation 
when it was under the control of Ig regulatory elements (  28, 
48, 67, 68  ). 
  The higher level of mutation we found proximal to the 
translocation breakpoints is analogous to what is observed for 
switch region junctions (  69  ). However, the mutation break-
points proximal to the   c-myc   to Ig V-J  H   region translocations 
are not RGYW hotspot biased and diff  er from breakpoint 
distal mutations in that they are not enriched for transitions. 
This suggests that the higher mutation frequency within 20 
nts of the junction is the result of error-prone repair by non-
homologous end joining, whereas many of the mutations 
further away from the breakpoint are AID induced. 
  We conclude that translocations involving the Ig V-J  H   
region of the Ig locus can be attributed to lesions produced 
by AID. 
  MATERIALS AND METHODS 
  DNA preparation and PCR.     Hyperplastic lymph nodes from individual 
male and female   IL-6   tg (  14  ) and   AID       /       IL-6   tg (  12  ) mice were combined 
into four pools. Total DNA was prepared from 2       10  7   cells for each pool. 
0.5       10  6   cells from each of the four pools for 12 diff  erent mice was assayed 
for derivative 12 translocations by PCR using primer set 1 and 2.5       10  6   
cells using primer set 2 (see below). For derivative 15 translocations, 0.5       
10  6   cells from each of the four pools from 12 diff  erent mice was amplifi  ed 
using set 3 (see below). 
  For derivative 12 translocations from c-myc to the IgH variable re-
gion, we performed nested PCR (Long Expand PCR system; Roche) using 
the following primers: primer set 1: fi  rst round with 5-  GCAATGACT-
GAA  GACTCAGTCCCTCTTAAG-3   (  IgH  ) and   ACTTAGCCCTGC  -
A  GAC  GCCCAGGAATCGCC   (  c-myc  ), followed by nested PCR with JEM VOL. 204, September 3, 2007 
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